Bicyclic Peptides as Next-Generation Therapeutics

Chemistry. 2017 Sep 18;23(52):12690-12703. doi: 10.1002/chem.201702117. Epub 2017 Jul 27.

Abstract

Bicyclic peptides have greater conformational rigidity and metabolic stability than linear and monocyclic peptides and are capable of binding to challenging drug targets with antibody-like affinity and specificity. Powerful combinatorial library technologies have recently been developed to rapidly synthesize and screen large bicyclic peptide libraries for ligands against enzymes, receptors, and protein-protein interaction targets. Bicyclic peptides have been developed as potential therapeutics against a wide range of diseases, drug targeting agents, imaging/diagnostic probes, and research tools. In this Minireview, we provide a summary of the recent progresses on the synthesis and applications of bicyclic peptides.

Keywords: click chemistry; combinatorial chemistry; peptides; phage display; protein-protein interactions.

Publication types

  • Review

MeSH terms

  • Bridged Bicyclo Compounds / chemistry*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Neoplasms / diagnostic imaging
  • Peptide Library
  • Peptides, Cyclic / chemical synthesis
  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / pharmacology
  • Positron-Emission Tomography
  • Protein Interaction Domains and Motifs / drug effects
  • Receptors, Glucagon / antagonists & inhibitors

Substances

  • Bridged Bicyclo Compounds
  • Enzyme Inhibitors
  • Peptide Library
  • Peptides, Cyclic
  • Receptors, Glucagon